Although cancer immunotherapy has achieved considerable advancements in recent years, the immune evasion is a major challenge in improving the clinical effectiveness of immunotherapy.[31, 32, 33] Here, we show that KMT5C has a crucial role in regulation of tumor immune evasion in lung cancer. This evidence concerns the gene KMT5C and lung cancer.